• ANTIPLATELET THERAPY AFTER PCI. 2021 ACC/AHA/SCAI GUIDELINES

  • Jan 22 2022
  • Duración: 28 m
  • Podcast

ANTIPLATELET THERAPY AFTER PCI. 2021 ACC/AHA/SCAI GUIDELINES

  • Resumen

  • ANTIPLATELET THERAPY BEFORE / DURING & AFTER PCI and CABG - 2021 ACC/AHA/SCAI GUIDELINES. A lot has changed in the field of Antiplatelet and antithrombotic therapy in patients undergoing #PCI or CABG. New evidence from trials like TWILIGHT trial, STOPDAPT trial, GLASSY & GLOBAL LEADER trial has made us reconsider what is optimal Antiplatelet Therapy for patients undergoing CABG and PCI. The new ACC/ AHA/ SCAI Guidelines have considered these evidence and have given new recommendations for patients undergoing #coronary revascularization. Let's take a deep dive into the topic. We have discussed 2021 ACC/AHA/SCAI GUIDELINES under various headings in the following videos and podcast. Do have a look. Revascularization in STEMI https://youtu.be/SknUePl9KzQ Revascularization in NSTE-ACS https://youtu.be/hul1sRuxezg Revascularization in stable CAD https://youtu.be/fyHM6KJ9B_M
    Más Menos

Lo que los oyentes dicen sobre ANTIPLATELET THERAPY AFTER PCI. 2021 ACC/AHA/SCAI GUIDELINES

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.